Provider
QP65-26 Update for New-to-Market Medical Drugs: bevacizumab-vikg (Lytenava)
Program effective Date: Sep 23, 2026
Program effective Date: Sep 23, 2026
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2026
Step Therapy, Quantity Limit
Program effective Date: Oct 01, 2026
Prior Authorization
Program effective Date: Oct 01, 2026
Quantity Limit
Program effective Date: Oct 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2026
Step Therapy, Quantity Limit
Program effective Date: Oct 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2026
Prior Authorization
Program effective Date: Oct 01, 2026